<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>MARBURG FEVER: CHARACTERISTICS AND CLINICAL-EPIDEMIOLOGICAL FEATURES</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Muhammadali</mods:namePart><mods:namePart type="family">Bo'riyev</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Malohat</mods:namePart><mods:namePart type="family">Himmatova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Marburg virus disease is an acute viral infection characterized by a hemorrhagic syndrome and a high case fatality rate. It is caused by the Marburg virus, which belongs to the Filoviridae family.
This article provides an in-depth analysis of the epidemiology, pathogenesis, clinical manifestations, laboratory diagnostics, and preventive measures of the disease. Research findings indicate that Marburg fever is distinguished by high transmissibility and a case fatality rate ranging from 24% to 88%, making it a significant global public health concern.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-05-30</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>SIR Publishers</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>